In Silico Evaluation of the Thr58-Associated Conserved Water with KRAS Switch-II Pocket Binders.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
13 03 2023
Historique:
pubmed: 1 3 2023
medline: 15 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

The KRAS switch-II pocket (SII-P) has proven to be one of the most successful tools for targeting KRAS with small molecules to date. This has been demonstrated with several KRAS(G12C)-targeting covalent inhibitors, already resulting in two FDA-approved drugs. Several earlier-stage compounds have also been reported to engage KRAS SII-P with other position 12 mutants, including G12D, G12S, and G12R. A highly conserved water molecule exists in the KRAS SII-P, linking Thr58 of switch-II and Gly10 of β1 sheet. This conserved water is also present in the cocrystal structures of most of the disclosed small-molecule inhibitors but is only displaced by a handful of SII-P binders. Here, we evaluated the conserved water molecule energetics by the WaterMap for the SII-P binders with publicly disclosed structures and studied the water behavior in the presence of selected inhibitors by microsecond timescale molecular dynamics (MD) simulations using two water models (total simulation time of 120 μs). Our data revealed the high-energy nature of this hydration site when coexisting with an SII-P binder and that there is a preference for a single isolated hydration site in this location within the most advanced compounds. Furthermore, water displacement was only achieved with a few disclosed compounds and was suboptimal, as for instance a cyanomethyl group as a water displacer appears to introduce repulsion with the native conformation of Thr58. These results suggested that this conserved water should be considered more central when designing new inhibitors, especially in the design of noncovalent inhibitors targeting the SII-P.

Identifiants

pubmed: 36854010
doi: 10.1021/acs.jcim.2c01479
pmc: PMC10015465
doi:

Substances chimiques

Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1490-1505

Références

ACS Omega. 2019 Feb 28;4(2):2921-2930
pubmed: 30842983
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Nat Commun. 2018 Aug 9;9(1):3169
pubmed: 30093669
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):808-13
pubmed: 17204562
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15823-15829
pubmed: 31332011
Comput Struct Biotechnol J. 2019 Dec 26;18:189-198
pubmed: 31988705
Cancer Discov. 2022 Jun 2;12(6):1500-1517
pubmed: 35404998
Bioorg Med Chem. 2022 Oct 1;71:116949
pubmed: 35926326
Nat Med. 2022 Oct;28(10):2171-2182
pubmed: 36216931
Structure. 2017 Sep 5;25(9):1442-1448.e3
pubmed: 28781083
Proteins. 2004 May 1;55(2):351-67
pubmed: 15048827
Nucleic Acids Res. 2018 Jan 4;46(D1):D486-D492
pubmed: 29126160
J Med Chem. 2020 Jul 9;63(13):6679-6693
pubmed: 32250617
Nat Genet. 2006 Mar;38(3):331-6
pubmed: 16474405
Cell Discov. 2022 Jan 25;8(1):5
pubmed: 35075146
Nat Chem Biol. 2022 Nov;18(11):1177-1183
pubmed: 35864332
Nat Struct Mol Biol. 2018 Jun;25(6):454-462
pubmed: 29760531
J Med Chem. 2020 May 14;63(9):4468-4483
pubmed: 32023060
Hum Mutat. 2011 Jan;32(1):33-43
pubmed: 20949621
J Med Chem. 2022 Feb 24;65(4):3123-3133
pubmed: 34889605
Cell. 2018 Jan 25;172(3):578-589.e17
pubmed: 29373830
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2545-2550
pubmed: 30683716
J Chem Theory Comput. 2021 Jul 13;17(7):4291-4300
pubmed: 34096718
ChemMedChem. 2020 Jul 3;15(13):1200-1215
pubmed: 32358915
Nat Chem Biol. 2022 Jun;18(6):596-604
pubmed: 35314814
Cancer Res. 2020 Sep 1;80(17):3719-3731
pubmed: 32605999
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5299-304
pubmed: 22431598
ChemMedChem. 2020 May 19;15(10):827-832
pubmed: 32237114
Nat Rev Drug Discov. 2022 Dec;21(12):881-898
pubmed: 36008483
ACS Med Chem Lett. 2019 Aug 20;10(9):1302-1308
pubmed: 31531201
Nature. 2019 Nov;575(7781):217-223
pubmed: 31666701
Nat Chem Biol. 2014 Feb;10(2):127-32
pubmed: 24292070
Nat Biotechnol. 2022 May;40(5):769-778
pubmed: 34992247
J Med Chem. 2016 May 12;59(9):4035-61
pubmed: 26807648
J Am Chem Soc. 2008 Mar 5;130(9):2817-31
pubmed: 18266362
Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3
pubmed: 28781124
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nat Commun. 2021 Feb 19;12(1):1176
pubmed: 33608534
J Am Chem Soc. 2022 Sep 7;144(35):15916-15921
pubmed: 36001446
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):
pubmed: 34983849
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):17889-94
pubmed: 22011572
ChemMedChem. 2022 Nov 18;17(22):e202200392
pubmed: 35979853
J Med Chem. 2020 Jan 9;63(1):52-65
pubmed: 31820981
Angew Chem Int Ed Engl. 2022 Aug 1;61(31):e202112919
pubmed: 35648650
Chem Sci. 2020 Nov 19;12(3):960-968
pubmed: 34163862
Cancer Discov. 2016 Mar;6(3):316-29
pubmed: 26739882
Chem Soc Rev. 2021 Aug 21;50(16):9104-9120
pubmed: 34184009
Nucleic Acids Res. 2021 Jul 2;49(W1):W431-W437
pubmed: 33956157
J Comput Aided Mol Des. 2019 Mar;33(3):307-330
pubmed: 30756207
ACS Med Chem Lett. 2018 Nov 07;9(12):1230-1234
pubmed: 30613331
Sci Rep. 2020 Jul 20;10(1):11992
pubmed: 32686745
J Med Chem. 2022 Nov 10;65(21):14614-14629
pubmed: 36300829
J Mol Biol. 2002 Jul 12;320(3):597-608
pubmed: 12096912
J Med Chem. 2017 Aug 24;60(16):6781-6827
pubmed: 28475332
Nat Rev Drug Discov. 2020 Aug;19(8):533-552
pubmed: 32528145
J Med Chem. 2022 Jan 27;65(2):1283-1301
pubmed: 34213342
Biochemistry. 2017 Jun 27;56(25):3178-3183
pubmed: 28621541
J Comput Aided Mol Des. 2022 Aug;36(8):591-604
pubmed: 35930206
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
J Med Chem. 2022 May 12;65(9):6940-6952
pubmed: 35471939
Nature. 2013 Nov 28;503(7477):548-51
pubmed: 24256730
J Am Chem Soc. 2009 Oct 28;131(42):15403-11
pubmed: 19778066
J Mol Recognit. 2019 Dec;32(12):e2810
pubmed: 31456282
Clin Cancer Res. 2022 Apr 14;28(8):1482-1486
pubmed: 34903582

Auteurs

Renne Leini (R)

School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1C, 70210 Kuopio, Finland.

Tatu Pantsar (T)

School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1C, 70210 Kuopio, Finland.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female

Classifications MeSH